BLACK FRIDAY EARLY — BOGO 50% SITEWIDE

Thymalin vs Thymogen: Polypeptide Extract vs Synthetic Dipeptide, and What the Evidence Actually Shows

By the Ageless Humans editorial team · Updated 2026-11-14 · 7 min read

Thymalin and thymogen are both thymic bioregulators from the same Soviet-era research program led by Vladimir Khavinson and Vladimir Morozov, but they are different materials. Thymalin is a complex mix of polypeptides extracted from calf thymus. Thymogen is a single synthetic dipeptide, L-glutamyl-L-tryptophan (Glu-Trp), identified as an active fragment within that extract. Both have decades of Russian clinical use and research behind them, but the evidence base is narrow, mostly from one research network, and neither is approved by the FDA or sold as a dietary supplement in the US.

The Short Answer: How Thymalin and Thymogen Differ

The core difference is composition. Thymalin is a biological extract containing many peptides at once. Thymogen is one precisely defined molecule made in a lab. Everything else, including consistency, research design, and how each is described, follows from that.

  • Thymalin: a polypeptide complex isolated from the thymus glands of calves. It is a mixture, not a single compound.
  • Thymogen: the dipeptide Glu-Trp, two amino acids (glutamic acid and tryptophan) joined together. It is chemically synthesized, so every batch is the same molecule.
  • Shared purpose: both were developed to study and support the immune-regulating role of the thymus, the small gland behind the breastbone where T cells mature.

Think of thymalin as the original whole-tissue approach and thymogen as the attempt to isolate the part that matters. Whether that isolated part captures everything the extract does is still an open research question.

Where Both Came From: The Khavinson-Morozov Lineage

Both compounds come out of the same research program at the Military Medical Academy in Leningrad, beginning in the 1970s. Vladimir Khavinson and Vladimir Morozov were studying whether peptides extracted from specific organs could help regulate the function of those same organs. They called these substances "peptide bioregulators."

Thymalin came first. It was one of the earliest organ-derived peptide extracts from this group, and it later became an approved pharmaceutical product in the USSR and then Russia. As the researchers analyzed the extract, they worked to identify which small peptide fragments were responsible for its activity. Glu-Trp emerged from that work and was developed into thymogen. Outside Russia, the same Glu-Trp molecule has also been studied under the international name oglufanide.

The lineage continued. Khavinson went on to lead the St. Petersburg Institute of Bioregulation and Gerontology, where the program moved toward ever-shorter synthetic peptides, such as epitalon (a tetrapeptide) and vilon (the dipeptide Lys-Glu). Knowing this history matters for one reason: most of the published research on thymalin and thymogen traces back to this single network of investigators. That is not disqualifying, but it is important context for judging the evidence.

Thymalin: The Polypeptide Extract

Thymalin is a mixture of thymus-derived peptides, so its exact composition is less defined than a synthetic compound. It is produced by extracting and purifying peptide fractions from calf thymus tissue. Analyses published by the Khavinson group describe a blend of short peptides, with Glu-Trp among the identified components.

The extract approach has a logical appeal. If the thymus communicates through a network of signaling peptides, a whole-tissue extract might deliver more of that network than any single molecule. Researchers in this lineage have studied thymalin for its effects on markers of immune function, including T-cell populations and the balance between immune cell types, often in older adults and in hospital settings.

The trade-offs are real:

  • Batch variability: biological extracts can vary with source tissue and processing.
  • Harder to study precisely: when results appear, it is difficult to say which component caused them.
  • Animal-derived: this matters for sourcing standards and for some people's personal preferences.

For a deeper look at what has been studied, see our guide to thymalin benefits.

Thymogen: The Synthetic Dipeptide

Thymogen is a single, fully defined molecule, Glu-Trp, which makes it more reproducible and easier to study than an extract. Because it is synthesized rather than extracted, there is no tissue sourcing and no batch-to-batch question about what is inside, assuming the product is legitimately made.

In Russia, thymogen has been registered as a pharmaceutical and studied in several forms, including injectable, intranasal, and topical preparations. Research in this lineage has looked at its role in immune signaling, with attention to T-cell function and to how immune cells respond under stress. Separately, oglufanide (the same Glu-Trp molecule) received some research attention outside Russia, which gives it a slightly broader footprint than thymalin, though it remains limited.

The open question is whether two amino acids can stand in for a whole extract. A dipeptide is small, simple, and well characterized. That is a strength for research and quality control. It may also mean it does less than the full mix. Current evidence doesn't settle that. Read more in our breakdown of thymogen benefits.

Thymalin vs Thymogen: Side-by-Side

If you only want the comparison, here it is in one place.

  • What it is: Thymalin is a polypeptide complex. Thymogen is the single dipeptide Glu-Trp.
  • Source: Thymalin is extracted from calf thymus. Thymogen is chemically synthesized.
  • Consistency: Thymalin depends on extraction and purification. Thymogen is identical molecule to molecule.
  • Origin: Both come from the Khavinson-Morozov program; thymalin came first, and thymogen was derived from research on it.
  • Forms studied: Thymalin is mainly studied as an injectable. Thymogen has been studied as injectable, intranasal, and topical preparations.
  • International research: Thymalin research is almost entirely Russian-language. Thymogen has some additional work under the name oglufanide.
  • US status: Neither is FDA-approved, and neither is a legal dietary supplement ingredient.

One practical point: neither is a capsule supplement in its studied form. Most research involves pharmaceutical preparations given under medical supervision, not oral products. That alone separates them from anything you'd find on a supplement shelf.

What the Evidence Does and Doesn't Show

The honest summary: there is a long history of use and a meaningful body of Russian research, but very little independent, large-scale, modern trial data. Both compounds deserve curiosity. Neither has the evidence to justify strong claims.

What the research does show:

  • Decades of clinical use in Russia within a regulated pharmaceutical system.
  • Many published studies on immune markers, especially T-cell function, from the developing research group.
  • Long-term observational work in older adults within the Khavinson lineage, which has been studied for links to healthy aging, though those designs were not modern large randomized trials.

What it doesn't show:

  • Replication by fully independent research groups at scale.
  • Large, preregistered, placebo-controlled trials that meet current international standards.
  • Clear evidence that oral or non-pharmaceutical versions behave like the studied preparations.
  • Head-to-head trials directly comparing thymalin with thymogen.

That last gap matters most for this comparison. No good evidence shows that one is better than the other. Any source declaring a winner is going beyond the data. The fair framing is that they represent two philosophies: whole extract vs isolated fragment. Both remain under-studied by Western standards.

Legal Status, Sourcing, and Safety Realities in the US

In the US, thymalin and thymogen are not FDA-approved drugs and are not legal dietary supplement ingredients. Products sold online under these names are often labeled "for research use only," which means they are not made or tested for human use under any US standard.

That creates real risks that have nothing to do with the molecules themselves:

  • Identity: you can't verify that the vial contains what the label says.
  • Purity and sterility: injectable products made outside regulated systems may be contaminated.
  • Dose accuracy: concentration claims are rarely verified.
  • Animal-tissue sourcing: for extracts like thymalin, origin and screening of source tissue are usually unknown.

If you're interested in these compounds, talk with a licensed physician who knows your health history. Treat claims from peptide vendors with skepticism, especially claims that go beyond what the research above supports.

Supporting the Thymus-Immune Axis With Everyday Foundations

The thymus naturally shrinks with age, a process called thymic involution, and that's the reason researchers became interested in thymic peptides in the first place. The gland gradually gets replaced by fatty tissue and produces fewer new T cells over time. That biology is well established. How much any intervention can change it is not.

What you can control are the foundations that help maintain healthy immune function: sleep, protein intake, regular movement, stress management, and the nutrients immune cells rely on. Glutathione, the body's master antioxidant, is one of them. Immune cells use it to manage oxidative stress, and the body makes it from cysteine, glycine, and glutamate. A precursor formula like GlutaBoost supplies those building blocks to support your body's own glutathione production.

For people who want a broader, structured routine, the Metamorphic Anti-Aging Protocol combines several longevity-focused formulas into one system built to support cellular health as you age. Neither product is a thymic peptide or a substitute for one. They're legal, label-transparent supplements for the daily basics that every healthy-aging strategy depends on.

Related reading & products

Frequently asked questions

What is the main difference between thymalin and thymogen?+

Thymalin is a mixture of many peptides extracted from calf thymus tissue, while thymogen is a single synthetic dipeptide, glutamyl-tryptophan (Glu-Trp). Thymogen was identified through research on thymalin as one of its active fragments. The result is that thymalin is a broader but less precisely defined material, and thymogen is a narrower but fully defined molecule.

Is thymogen the same as oglufanide?+

Yes, thymogen and oglufanide refer to the same molecule, the dipeptide L-glutamyl-L-tryptophan (Glu-Trp). Thymogen is the name used for the Russian pharmaceutical product, while oglufanide is the international nonproprietary name used in some research outside Russia. Formulations and preparations can differ even when the core molecule is the same.

Is thymalin or thymogen better?+

No high-quality head-to-head trials directly compare thymalin and thymogen, so there's no evidence-based answer to which is better. They represent two approaches: a whole-tissue peptide extract versus one isolated, synthetic fragment. Thymogen offers more consistency, while thymalin offers a broader mix of peptides whose individual roles are not fully understood.

Who developed thymalin and thymogen?+

Both were developed by Vladimir Khavinson and Vladimir Morozov, beginning in the 1970s at the Military Medical Academy in Leningrad, as part of their research into organ-derived peptide bioregulators. Thymalin came first as a thymus extract, and thymogen followed after the team identified Glu-Trp as an active component. Khavinson later led the St. Petersburg Institute of Bioregulation and Gerontology, which developed other short peptides such as epitalon.

Are thymalin and thymogen legal in the United States?+

Neither thymalin nor thymogen is approved by the FDA, and neither is a legal dietary supplement ingredient in the US. Products sold online under these names are often labeled for research use only, meaning they are not manufactured or tested for human use under US standards. Anyone considering them should speak with a licensed physician first.

How strong is the research on thymic bioregulators?+

Research on thymalin and thymogen spans decades, but most of it comes from one Russian research network and was published in Russian-language journals. Studies have examined immune markers such as T-cell function, yet large, independent, placebo-controlled trials by modern international standards are largely missing. The fair conclusion is that these compounds are interesting and studied, but not well established.

Keep reading